Euro Manganese Announces Grant of Stock Options

VANCOUVER, British Columbia, Sept. 11, 2020 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V/ASX: EMN) (the “Company” or “EMN“), announces that the Company has granted stock options to its directors, officers and employees to purchase up to an aggregate of 3,950,00 common shares of the Company.  Of these, 1,653,000 have been […] Lire la suite »

Nordea Board of Directors resolves on a transfer

COPENHAGEN, Denmark, Sept. 11, 2020 (GLOBE NEWSWIRE) — Nordea Board of Directors resolves on a transfer of own shares pursuant to variable remuneration programmes Nordea Bank AbpStock exchange release – Other information disclosed according to the rules of the Exchange11 September 2020 at 17.00 EET Nordea Bank Abp’s (“Nordea”) Board […] Lire la suite »

Prasinezumab Slows Progression on Measures of Parkinson’s Disease in Phase 2 Study

First potentially disease-modifying, anti-alpha-synuclein antibody to demonstrate signals of efficacy on multiple pre-specified secondary and exploratory clinical endpoints, including measures of motor function and biomarkers, in patients with early Parkinson’s disease Significantly reduced decline in motor function by 35% vs. placebo at one year and delayed time to clinically meaningful […] Lire la suite »

New Data at ACTRIMS-ECTRIMS Meeting Showcase Safety and Efficacy of Biogen’s Industry-Leading MS Portfolio

New data from ongoing Phase 3 study further define the effectiveness and improved GI tolerability of VUMERITY® (diroximel fumarate) Real-world findings evaluate quality of life benefits associated with TYSABRI® (natalizumab) when compared to Ocrevus®(ocrelizumab) Additional real-world findings report positive benefits of PLEGRIDY® (peginterferon beta-1a) and AVONEX® (interferon beta-1a) in older […] Lire la suite »

Ressources Robex Inc. : nouveau dividende extraordinaire de 4 cents par action et doublement des ressources indiquées

QUÉBEC, 11 sept. 2020 (GLOBE NEWSWIRE) — Ressources Robex Inc. (« Robex » ou « la Société ») (TSXV : RBX/FWB : RB4) est heureuse de publier un rapport d’étape de sa campagne d’exploration en cours. AVANCEMENT DE LA CAMPAGNE EN COURS Robex a annoncé la réalisation en 2020 d’une importante campagne d’exploration sur le site de […] Lire la suite »

Student Loans Company choisit Atos pour repenser son interface client

Londres, Royaume-Uni et Paris, France – 11 Septembre 2020 – Student Loans Company (SLC), organisme public non ministériel au Royaume-Uni qui offre des prêts aux étudiants, a choisi Atos, leader international de la transformation digitale, afin d’améliorer son interface client et l’infrastructure technologique associée. Atos soutiendra le développement des services […] Lire la suite »

Student Loans Company appoints Atos as a Strategic Partner

London, UK and Paris, France, 11 September 2020 – The Student Loans Company (SLC) has appointed Atos, a global leader in digital transformation, to support the delivery of improvements to SLC’s customer interface and the associated technology infrastructure. Atos will support the development of its Customer Enablement Services, with focus […] Lire la suite »

ePac annonce l’implantation de son premier site en France

ePac Lyon signe un nouvel épisode dans l’ambition du spécialiste de l’emballage souple de créer des sites locaux à travers l’Europe continentale. WOLVERHAMPTON, Royaume-Uni, 11 sept. 2020 (GLOBE NEWSWIRE) — Après la révélation de ses projets d’expansion, ePac Holdings Europe est heureuse d’annoncer l’ouverture de son premier site en France. […] Lire la suite »

Forterra Announces Favorable Decision in Earnout Arbitration

IRVING, Texas, Sept. 10, 2020 (GLOBE NEWSWIRE) — Forterra, Inc. (“Forterra” or “the Company”) (NASDAQ: FRTA), a leading manufacturer of water and drainage infrastructure pipe and products in the United States and Eastern Canada, today announced that a decision favorable to the Company has been rendered in the arbitration proceeding […] Lire la suite »

Junshi Biosciences Receives FDA Breakthrough Therapy Designation for Toripalimab for the Treatment of Nasopharyngeal Carcinoma

SHANGHAI, China, Sept. 10, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the US Food and Drug Administration (FDA) has recently granted Breakthrough Therapy designation (BTD) to Toripalimab for the […] Lire la suite »